These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29941651)

  • 21. Global distribution of bla
    Long H; Zhao F; Feng Y; Zong Z
    Int J Antimicrob Agents; 2024 May; 63(5):107141. PubMed ID: 38484805
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.
    Schroeder WA; Locke TR; Jensen SE
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3568-73. PubMed ID: 12384366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop.
    Winkler ML; Papp-Wallace KM; Bonomo RA
    J Antimicrob Chemother; 2015 Aug; 70(8):2279-86. PubMed ID: 25957381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactam.
    Chauzy A; Buyck J; de Jonge BLM; Marchand S; Grégoire N; Couet W
    Clin Microbiol Infect; 2019 Apr; 25(4):515.e1-515.e4. PubMed ID: 30543853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CTX-M-137, a hybrid of CTX-M-14-like and CTX-M-15-like β-lactamases identified in an Escherichia coli clinical isolate.
    Tian GB; Huang YM; Fang ZL; Qing Y; Zhang XF; Huang X
    J Antimicrob Chemother; 2014 Aug; 69(8):2081-5. PubMed ID: 24777903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.
    Perilli M; Segatore B; De Massis MR; Franceschini N; Bianchi C; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2002 Mar; 46(3):925-8. PubMed ID: 11850290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of defined cell envelope mutations in Escherichia coli on the in vitro antibacterial activity of avibactam/β-lactam combinations.
    McLeod SM; Patey SA; Huband MD; Nichols WW
    Int J Antimicrob Agents; 2017 Apr; 49(4):437-442. PubMed ID: 28242258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro susceptibility of characterized β-lactamase-producing strains tested with avibactam combinations.
    Li H; Estabrook M; Jacoby GA; Nichols WW; Testa RT; Bush K
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1789-93. PubMed ID: 25534728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012 and 2013.
    Biedenbach DJ; Kazmierczak K; Bouchillon SK; Sahm DF; Bradford PA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):4239-48. PubMed ID: 25963984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substitution of Thr for Ala-237 in TEM-17, TEM-12 and TEM-26: alterations in beta-lactam resistance conferred on Escherichia coli.
    Giakkoupi P; Hujer AM; Miriagou V; Tzelepi E; Bonomo RA; Tzouvelekis LS
    FEMS Microbiol Lett; 2001 Jul; 201(1):37-40. PubMed ID: 11445164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in
    Haidar G; Clancy CJ; Shields RK; Hao B; Cheng S; Nguyen MH
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent Emergence of Aztreonam-Avibactam Resistance in NDM and OXA-48 Carbapenemase-Producing Escherichia coli in Germany.
    Nordmann P; Yao Y; Falgenhauer L; Sadek M; Imirzalioglu C; Chakraborty T
    Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109021. PubMed ID: 34424048
    [No Abstract]   [Full Text] [Related]  

  • 33. Structural and sequence analysis of class A β-lactamases with respect to avibactam inhibition: impact of Ω-loop variations.
    Lahiri SD; Bradford PA; Nichols WW; Alm RA
    J Antimicrob Chemother; 2016 Oct; 71(10):2848-55. PubMed ID: 27402011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ; Amyes SG
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates.
    Calvopiña K; Hinchliffe P; Brem J; Heesom KJ; Johnson S; Cain R; Lohans CT; Fishwick CWG; Schofield CJ; Spencer J; Avison MB
    Mol Microbiol; 2017 Nov; 106(3):492-504. PubMed ID: 28876489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence of Aztreonam-Avibactam-Resistant NDM-5-Producing Escherichia coli in the Food Chain.
    Sadek M; Poirel L; Nordmann P
    Antimicrob Agents Chemother; 2021 Aug; 65(9):e0088221. PubMed ID: 34125588
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro susceptibility of characterized β-lactamase-producing Gram-negative bacteria isolated in Japan to ceftazidime-, ceftaroline-, and aztreonam-avibactam combinations.
    Yoshizumi A; Ishii Y; Aoki K; Testa R; Nichols WW; Tateda K
    J Infect Chemother; 2015 Feb; 21(2):148-51. PubMed ID: 25444674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and amino acid sequence of IRT-4, a novel TEM-type enzyme with a decreased susceptibility to beta-lactamase inhibitors.
    Brun T; Péduzzi J; Caniça MM; Paul G; Névot P; Barthélémy M; Labia R
    FEMS Microbiol Lett; 1994 Jul; 120(1-2):111-7. PubMed ID: 8056282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.